ALENTIS Trademark

Trademark Overview


On Monday, February 7, 2022, a trademark application was filed for ALENTIS with the United States Patent and Trademark Office. The USPTO has given the ALENTIS trademark a serial number of 79339676. The federal status of this trademark filing is REGISTERED as of Tuesday, August 15, 2023. This trademark is owned by Alentis Therapeutics AG. The ALENTIS trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment

Medical analysis services for diagnosing cancer; RNA or DNA analysis for cancer diagnosis and prognosis; provision of medical information in the field of cancer prevention, screening, diagnosis and treatment; medical advice and information regarding pharmaceutical and medical products; medical testing

Scientific and medical research and development in the field of fibrosis, autoimmune diseases, and cancer; biotechnological research services in the field of fibrosis, autoimmune diseases, and cancer; providing scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancerous diseases; scientific advice relating to medicine
alentis

General Information


Serial Number79339676
Word MarkALENTIS
Filing DateMonday, February 7, 2022
Status700 - REGISTERED
Status DateTuesday, August 15, 2023
Registration Number7135019
Registration DateTuesday, August 15, 2023
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, May 30, 2023

Trademark Statements


Description of MarkThe mark consists of the wording ALENTIS with the letter "A" stylized.
Goods and ServicesPharmaceutical products, for the treatment of cancer, autoimmune diseases, and organ fibrosis; chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer, autoimmune diseases, and organ fibrosis; biological preparations for medical and therapeutic use for the treatment of cancer, autoimmune diseases, and organ fibrosis; all the aforesaid goods not for ophthalmological use; biopharmaceutical products, namely, pharmaceutical preparations for cancer treatment
Goods and ServicesMedical analysis services for diagnosing cancer; RNA or DNA analysis for cancer diagnosis and prognosis; provision of medical information in the field of cancer prevention, screening, diagnosis and treatment; medical advice and information regarding pharmaceutical and medical products; medical testing
Goods and ServicesScientific and medical research and development in the field of fibrosis, autoimmune diseases, and cancer; biotechnological research services in the field of fibrosis, autoimmune diseases, and cancer; providing scientific research information in the pharmaceutical and biomedical field; scientific research for medical purposes in the field of cancerous diseases; scientific advice relating to medicine

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 6, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAlentis Therapeutics AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameAlentis Therapeutics AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameAlentis Therapeutics AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Monday, December 11, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, November 16, 2023FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 16, 2023FINAL DISPOSITION PROCESSED
Wednesday, November 15, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Saturday, October 21, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Tuesday, August 15, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, August 15, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 30, 2023NOTIFICATION PROCESSED BY IB
Tuesday, May 30, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023PUBLISHED FOR OPPOSITION
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 27, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, April 27, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 27, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, April 27, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, April 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 14, 2023REFUSAL PROCESSED BY IB
Tuesday, January 24, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, January 24, 2023REFUSAL PROCESSED BY MPU
Wednesday, November 23, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, November 22, 2022NON-FINAL ACTION WRITTEN
Saturday, November 19, 2022ASSIGNED TO EXAMINER
Thursday, November 10, 2022LIMITATION FROM THE IB EXAMINED AND ENTERED
Saturday, July 16, 2022LIMITATION OF GOODS RECEIVED FROM IB
Tuesday, May 10, 2022APPLICATION FILING RECEIPT MAILED
Friday, May 6, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 5, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB